P. J. Whitehead

发表

The relative power of heat‐precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: the Caerphilly and Speedwell studies

P. Elwood, G. Lowe, A. Rumley, 1998, British journal of haematology.

Clinical equivalence between salbutamol hydrofluoroalkane pMDI and salbutamol Turbuhaler at the same cumulative microgram doses in paediatric patients.

P. Gustafsson, P. J. Whitehead, S. Källman, 2002, Respiratory medicine.

A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma.

C. Goldfrad, H. Van Bever, P. J. Whitehead, 2007, Respiratory medicine.

Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patients with moderate-to-severe asthma.

A. Chuchalin, E. Maggi, P. J. Whitehead, 2002, Respiratory medicine.

Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies

P C Elwood, J R O'Brien, P. Elwood, 1991, Circulation.

The diagnosis of intra-abdominal abscesses in patients with severe Crohn's disease.

P. J. Whitehead, R. Harvey, A. Duncan, 1992, The Quarterly journal of medicine.

Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART).

M. Burr, A. Fehily, P. J. Whitehead, 1992, European heart journal.

Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis

R. Stockley, P. J. Whitehead, Michael Williams, 2006, Respiratory research.

The effect of different concentrations of lactose powder on the airway function of adult asthmatics.

T. Sandström, P. J. Whitehead, A. Wallin, 2001, Respiratory medicine.